From: A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection
Study
Treatment Group
Control Group
Groothuis 1993 (RSV-IGIV)
53.1
143.8
PREVENT 1997 (RSV-IGIV)
60
129
Simoes 1998 (RSV-IGIV)
72
107
IMPACT-RSV 1998 (Palivizumab)
36.4
62.6
Feltes 2003 (Palivizumab)
57.4